Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia

ClinicalTrials.gov ID: NCT01756339

Public ClinicalTrials.gov record NCT01756339. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 1:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Multi-Center Study to Evaluate the Efficacy and Safety of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in the Treatment of Adult Patients With Community-Acquired Bacterial Pneumonia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the safety and efficacy of an experimental antibiotic, solithromycin, in the treatment of adult patients with community-acquired pneumonia.

Study identification

NCT ID
NCT01756339
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Melinta Therapeutics, Inc.
Industry
Enrollment
860 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2012 (Type not available)
Primary completion
Oct 2014 (Actual)
Completion
Oct 2014 (Actual)
Last update posted
Mar 3, 2017

2012 – 2014

United States locations

U.S. sites
25
U.S. states
10
U.S. cities
21
Facility City State ZIP Site status
Not listed Glendale California 91206 —
Not listed Los Angeles California 90015 —
Not listed Mission Hills California 91345 —
Not listed Oxnard California 93030 —
Not listed Pasadena California 91105 —
Not listed Sylmar California 91342 —
Not listed Torrance California 90502 —
Not listed DeBary Florida 32713 —
Not listed DeLand Florida 32720 —
Not listed Miami Florida 33126 —
Not listed Miami Florida 33144 —
Not listed Saint Cloud Florida 34769 —
Not listed Tampa Florida 33606 —
Not listed Duluth Georgia 30096 —
Not listed New Bedford Massachusetts 02740 —
Not listed Butte Montana 59701 —
Not listed Columbus Ohio 43035 —
Not listed Downingtown Pennsylvania 19335 —
Not listed Summerville South Carolina 29485 —
Not listed Rapid City South Dakota 57702 —
Not listed Houston Texas 77011 —
Not listed Houston Texas 77030 —
Not listed Houston Texas 77070 —
Not listed Houston Texas 77093 —
Not listed Splendora Texas 77372 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 94 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01756339, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 3, 2017 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01756339 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →